Sana Biotechnology

Yahoo Finance • 13 days ago

Sector Update: Health Care Stocks Mixed Late Afternoon

Health care stocks were mixed late Friday afternoon, with the NYSE Health Care Index gaining 0.2% an PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 13 days ago

Sector Update: Health Care Stocks Advance Friday Afternoon

Health care stocks rose Friday afternoon, with the NYSE Health Care Index increasing 0.3% and the St PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 26 days ago

Sana Biotechnology, Inc. (SANA): A Bull Case Theory

We came across a bullish thesis on Sana Biotechnology, Inc. on Stock Invader’s Substack. In this article, we will summarize the bulls’ thesis on SANA. Sana Biotechnology, Inc.'s share was trading at $4.00 as of February 9th.Why Impact Biom... Full story

Yahoo Finance • last month

Genomics Stocks That Deserve a Place in Your Portfolio in 2026

An updated edition of the Jan. 6, 2026, article. Genomics is the comprehensive study of genomes—the complete set of deoxyribonucleic acid (DNA) within an organism. Rapid scientific progress in this field has intensified interest among pha... Full story

Yahoo Finance • 4 months ago

Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform

Data Demonstrate Potent in vivo Gene Editing of Hematopoietic Stem Cells (HSCs) in the Bone Marrow with Systemic Delivery in Preclinical Murine Models Using Fusogen Technology Broadens Application of Fusogen Technology Beyond T Cells to S... Full story

Yahoo Finance • 4 months ago

Sana (SANA) Surges 14.5% Ahead of Business Announcements

We recently published 10 Small Stocks with Mighty Gains. Sana Biotechnology, Inc. (NASDAQ:SANA) is one of the top-performing stocks on Wednesday. Sana Biotechnology soared by 14.53 percent on Wednesday to finish at $4.02 apiece as investo... Full story

Yahoo Finance • 4 months ago

Sana Biotechnology to Present at December 2025 Investor Conferences

SEATTLE, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor... Full story

Yahoo Finance • 4 months ago

The Biotech Sector is Seeing a Major Boost From Programmable Cell Therapies in Chronic Disease Care

Issued on behalf of Avant Technologies Inc. VANCOUVER, British Columbia, Nov. 19, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – The autologous cell therapy market surpassed $10.1 billion in 2025 as biotechnology companies ra... Full story

Yahoo Finance • 4 months ago

Sana Biotechnology (SANA) Wins Analyst Support With Strategic Focus and Cash Strength

Sana Biotechnology Inc. (NASDAQ:SANA) is a must-buy penny stock according to analysts. On November 7, Bank of America Securities analyst Alec Stranahan reaffirmed a Buy rating on Sana Biotechnology (NASDAQ: SANA) and set a price target of... Full story

Yahoo Finance • 5 months ago

The Math Shows FHLC Can Go To $79

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied... Full story

Yahoo Finance • 5 months ago

Sana Biotech surges as Eric Jackson calls it a 100-bagger

[US 100 dollar bill folded into an up arrow on wooden table. Illustration of the concept of inflation, profit, earning and investment] Dragon Claws/iStock via Getty Images Shares of Sana Biotechnology (NASDAQ:SANA [https://seekingalpha.co... Full story

Yahoo Finance • 6 months ago

TruBridge, Inc. (TBRG): A Bull Case Theory

We came across a bullish thesis on TruBridge, Inc. (TBRG) on Negócios pelo Mundo’s Substack by Leo Caroli. In this article, we will summarize the bulls’ thesis on TBRG. TruBridge, Inc. (TBRG)'s share was trading at $21.79 as of September 1... Full story

Yahoo Finance • 7 months ago

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

RESEARCH TRIANGLE PARK, N.C. and CAMBRIDGE, Mass., Aug. 28, 2025 /PRNewswire/ -- IQVIA (NYSE: IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, and Flagship Pioneering, the biop... Full story

Yahoo Finance • 7 months ago

Sana Biotechnology to Present at September 2025 Investor Conferences

SEATTLE, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at four investor... Full story

Yahoo Finance • 7 months ago

Sana Biotechnology Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares

SEATTLE, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it has closed the sale of 3,358,208 share... Full story

Yahoo Finance • 8 months ago

Sana Biotechnology prices $75 million public offering at $3.35 per share

SEATTLE - Sana Biotechnology, Inc. (NASDAQ:SANA), whose stock has surged over 160% year-to-date with a current market capitalization of approximately $959 million, has priced its underwritten public offering of 20,895,522 shares of common... Full story

Yahoo Finance • 8 months ago

Sana Biotechnology drops 13% on $75M stock issuance, prices at $3.35

* Sana Biotechnology (NASDAQ:SANA [https://seekingalpha.com/symbol/SANA]) priced [https://seekingalpha.com/pr/20192464-sana-biotechnology-announces-pricing-of-public-offering] its underwritten public offering of ~20.89M shares at $3.35 p... Full story

Yahoo Finance • 8 months ago

Sana Biotechnology Announces Pricing of Public Offering

SEATTLE, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it has priced its underwritten public off... Full story

Yahoo Finance • 8 months ago

Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

SEATTLE, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it has commenced an underwritten public o... Full story

Yahoo Finance • 8 months ago

Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates

Seres Therapeutics, Inc. Following FDA input, Seres submitted Phase 2 study protocol to FDA for SER-155 for the prevention of bloodstream infections (BSIs) in adults undergoing allogeneic hematopoietic stem cell transplant (allo-HSCT) to... Full story